Stem Cells News and Research

RSS

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

Scientists identify new way of attacking breast cancer stem cells

Scientists at the University of Michigan Comprehensive Cancer Center have identified a potential new way of attacking breast cancer stem cells, the small number of cells in a tumor that fuel its growth and spread.

18 Jan 2011

Study finds miRNAs inhibits prostate cancer metastasis

A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells. A research team led by scientists at The University of Texas MD Anderson Cancer Center reported today in an advance online publication at Nature Medicine.

18 Jan 2011

Stem cell exhibition to broaden debate on the issue

The topic remains complex and controversial, the technology innovative and promising, and the debate, on stem-cell research, continues unabated. And now, the subject is receiving the attention of a group not normally associated with scientific discoveries. University of Alberta printmaking professor, Sean Caulfield, along with U of A Health Law Institute research director and researcher, Tim Caulfield, have brought together a group of visual artists from Europe and North America to contribute to the stem-cell debate that often pits politicians, scientists, pundits and religious leaders against each other.

17 Jan 2011

Health Canada requests Osiris for additional information in support of Prochymal approval

Osiris Therapeutics, Inc. today announced that Health Canada has requested additional information in support of the Company's application for approval of Prochymal, a stem cell therapy, for the treatment of graft vs. host disease (GvHD).

14 Jan 2011

University of Illinois receives Friends of Mel Foundation support grant for Bone Marrow Transplant Program

The University of Illinois is set to receive a grant from the Friends of Mel Foundation (FOM) in support of their Bone Marrow Transplant Program. The program was selected as the recipient of the Mel's Magic award for January 2011. Mel's Magic was created by FOM in May 2009 to familiarize their supporters with other organizations that work tirelessly to make a difference in the cancer community.

14 Jan 2011

Cancer Research UK and CRT select 4 research groups to unravel role of cancer stem cells

Cancer Research UK and its commercial arm Cancer Research Technology (CRT), have established a team of scientists with expertise in cancer stem cell research to identify new targets to detect, monitor and treat cancer.

14 Jan 2011

Vitrolife receives patent protection for Swemed Sense needle in European markets

Swemed Sense™ is a unique needle that is used for the collection of oocytes in connection with IVF. The approved patent means that Vitrolife has both design protection and product patent protection for Swemed Sense™ in strategically important European markets. A patent has also been applied for in other prioritized markets.

14 Jan 2011

MGH researchers discover massive overexpression of DNA sequences in cancer cells

Massachusetts General Hospital Cancer Center researchers have discovered a previously unknown feature of common tumor cells - massive overexpression of certain DNA sequences that do not code for proteins.

14 Jan 2011

Scientists develop Australia's first pluripotent stem cell lines using skin biopsies for FA disease

Scientists have developed Australia's first adult induced pluripotent stem cell lines using skin biopsies from patients with the rare genetic disease Friedreich Ataxia.

14 Jan 2011

Biocordcell Argentina launches program to store dental pulp stem cells

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that Biocordcell Argentina S.A. (BioCells, Inc.) has launched a program to store dental pulp stem cells, the first stem cell storage bank in Argentina to offer this service.

13 Jan 2011

BP-lowering medications provide long-term benefit of reducing death risk from cardiovascular disease

In a study published in December 2010, in Hypertension, a journal of the American Heart Association, investigators have shown that early treatment with blood pressure-lowering medications provides a long-term benefit of reducing the risk of death from cardiovascular disease.

13 Jan 2011

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.

13 Jan 2011

Medical breakthrough: Surgeons use stem cells from patient's fat for cosmetic procedure

We've all heard stories about medical breakthroughs involving stem cells in recent years. But stem cells and cosmetic surgery? "We've learned that your own fat is a great source for stem cells," says Dr. Mark Berman, MD, President of the American Academy of Cosmetic Surgery. "With our current technology, we can harvest fat and actually separate the stem cells."

13 Jan 2011

Stem cell therapy enters anti-aging industry

While many scientists may state that stem cells are the key to longer and healthier lives, some are not waiting on the technology for that and are using it in the anti-aging industry to bring unmatched results in wrinkle removal. The ant-wrinkle and skin cream industry has been in a state of remission as far as advancements in the industry for decades.

12 Jan 2011

CE mark approves Vitrolife's SpermFreeze Solution

SpermFreeze Solution, which is used for freeze storage of sperm, has obtained a CE mark and is thereby approved for sales within the European Economic Area.

12 Jan 2011

Emerging Healthcare enters option agreement with OceanBASIS

Emerging Healthcare Solutions, Inc. announced today that it has entered into an option agreement with OceanBASIS, a German company specializing in stem-cell and marine-collagen technologies and products.

12 Jan 2011

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

Transplanting their own bone marrow-derived stem cells into 48 patients with end-stage liver disease resulted in therapeutic benefit to a high number of the patients, report researchers publishing in the current issue of Cell Transplantation. Yet, the mechanism by which the infusion of CD34+ stem cells improves liver function remains elusive, they say.

11 Jan 2011

Study supports use of telomerase inhibitors for treatment of childhood cancers

Geron Corporation today announced the publication of preclinical data demonstrating that the company's telomerase inhibitor drug, imetelstat (GRN163L), currently in Phase 2 clinical trials, selectively targets cancer stem cells in pediatric tumors of neural origin.

11 Jan 2011

Bioheart announces primary focus on completing clinical evaluation of cell therapies for heart failure

Bioheart, Inc. announced today that Bioheart's primary focus is on completing clinical evaluation of its cell therapies for treating heart failure and related cardiac diseases.

11 Jan 2011

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Researchers at Nationwide Children's Hospital report a gene therapy strategy that improves the condition of a mouse model of an inherited blood disorder, Beta Thalassemia.

11 Jan 2011

Stem Cells News and Research

Further Reading

Scientists identify new way of attacking breast cancer stem cells

Study finds miRNAs inhibits prostate cancer metastasis

Stem cell exhibition to broaden debate on the issue

Health Canada requests Osiris for additional information in support of Prochymal approval

University of Illinois receives Friends of Mel Foundation support grant for Bone Marrow Transplant Program

Cancer Research UK and CRT select 4 research groups to unravel role of cancer stem cells

Vitrolife receives patent protection for Swemed Sense needle in European markets

MGH researchers discover massive overexpression of DNA sequences in cancer cells

Scientists develop Australia's first pluripotent stem cell lines using skin biopsies for FA disease

Biocordcell Argentina launches program to store dental pulp stem cells

BP-lowering medications provide long-term benefit of reducing death risk from cardiovascular disease

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

Medical breakthrough: Surgeons use stem cells from patient's fat for cosmetic procedure

Stem cell therapy enters anti-aging industry

CE mark approves Vitrolife's SpermFreeze Solution

Emerging Healthcare enters option agreement with OceanBASIS

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

Study supports use of telomerase inhibitors for treatment of childhood cancers

Bioheart announces primary focus on completing clinical evaluation of cell therapies for heart failure

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Event guide: Supply Chain & Logistics for Cell & Gene Therapy eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo